Literature DB >> 8530627

Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM.

A B Cantor1, J P Krischer, D D Cuthbertson, D A Schatz, W J Riley, J Malone, S Schwartz, T Quattrin, N K Maclaren.   

Abstract

The international community of diabetologists is rapidly becoming involved in intervention trials aimed at preventing insulin-dependent diabetes in high risk relatives. Whereas age and relationship to a proband with insulin-dependent diabetes mellitus interacting with detected islet cell autoantibodies (ICA) are risk factors, their independent contribution to that risk remains unclear. In a prospective study of 6851 nondiabetic relatives of 2742 probands conducted between 1979-1993, we found age, but not relationship, to be a dramatic risk variable in ICA-positive persons as estimated by the Cox regression model. The 5-yr risk of insulin-dependent diabetes mellitus was 66% for those found to have ICA detectable before age 10 yr, falling progressively to less than 16% for ICA-positive relatives over age 40 yr. In ICA-negative relatives, age and relationship are independent prognostic variables.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530627     DOI: 10.1210/jcem.80.12.8530627

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.

Authors:  L I Alves; E Davini; M R Correia; R T Fukui; R F Santos; M R Cunha; D M Rocha; W M G Volpini; M E R Silva
Journal:  J Clin Immunol       Date:  2012-03-09       Impact factor: 8.317

2.  Prediction and prevention of IDDM.

Authors:  M Honeyman; C Wasserfall; J Nerup; A Rossini
Journal:  Diabetologia       Date:  1997-10       Impact factor: 10.122

3.  Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes.

Authors:  Blanca I Restrepo; Susan P Fisher-Hoch; Brian Smith; Sangchoon Jeon; Mohammad H Rahbar; Joseph B McCormick
Journal:  Am J Trop Med Hyg       Date:  2008-10       Impact factor: 2.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.